The US
Food and Drug Administration (FDA) approved TB medicine Bedaquiline will be
availed in Assam, Northeast at free of cost to the patient with
muti-drug-resistant tuberculosis.
First initiative
was taken in Northeast to launch the Bedaquiline, TB medicine in India before
distributing it to other medical outlets apart from Assam.
Free
diagnostic and treatment service will be assisted to the people by medical care
units under the Revised National TB Control Programme (RNTCP) including free
distribution of the TB medicine.
People
having TB symptoms like frequent cough for two weeks followed with additional
signs like excessive sweat, inflammation of the body and loss of weight are
cautioned by Health Services, Assam not to neglect and take the privilege of
the program.
No comments:
Post a Comment
Your highlight can be precious enough to make a change in the present system for better progress of the nation and so make a step to comment.